MaioRegen Prime for Knee Cartilage Damage
(OSTEOCONFIRM Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The present study aims to compare the efficacy and the safety of MaioRegen Prime to Debridement (SSOC) in patients with deep osteochondral lesions of the knee joint. The foreseen population involves patients with osteochondral lesions with different etiology, dimension, shape, and location.
The evaluation will be performed through clinical, subjective and objective assessments.
Are You a Good Fit for This Trial?
This trial is for adults aged 18-60 with significant knee cartilage and bone damage (deep osteochondral lesions) who haven't improved after at least 6 weeks of physical therapy. Participants must have a BMI of 35 or less, up to three treatable lesions in specific parts of the knee, and be able to follow rehab instructions.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- MaioRegen Prime
Trial Overview
The study compares two treatments for deep knee cartilage and bone injuries: an implant called MaioRegen Prime versus standard care involving cleaning out damaged tissue (debridement). Patients are assessed using both clinical exams and their own reports on symptoms.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Medical Device: MaioRegen Prime implant
Debridement
Find a Clinic Near You
Who Is Running the Clinical Trial?
Fin-Ceramica Faenza Spa
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.